Skip to content
Screener

Apimeds Pharmaceuticals US APUS Q1 2025 Annual earnings

Reported May 19, 2025 · Before market open

EPS-$0.05

Next report

Date not yet announced

FAQ

When did Apimeds Pharmaceuticals US report Q1 2025 earnings?
Apimeds Pharmaceuticals US (APUS) reported Q1 2025 earnings on May 19, 2025 before market open.
What were Apimeds Pharmaceuticals US's Q1 2025 revenue and EPS?
Apimeds Pharmaceuticals US reported eps of $-0.05 for Q1 2025.
Where can I find Apimeds Pharmaceuticals US's Q1 2025 SEC filings?
You can read the 8-K earnings release (0001213900-25-045643) and the 10-K periodic report (0001213900-25-032206) directly on SEC EDGAR. The filing index links above go to sec.gov.